LLY

19.9% of VHT Holdings Seeing Recent Insider Buys

A look at the weighted underlying holdings of the Vanguard Health Care ETF (VHT) shows an impressive 19.9% of holdings on a weighted basis have experienced insider buying within the past six months.

Eli Lilly (Symbol: LLY), which makes up 10.67% of the Vanguard Health Care ETF (VHT), has seen 8 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $1,875,550,471 worth of LLY, making it the #1 largest holding. The table below details the recent insider buying activity observed at LLY:

LLY — last trade: $762.93 — Recent Insider Buys:

Purchased Insider Title Shares Price/Share Value
08/08/2025 Jamere Jackson Director 200 $639.56 $127,913
08/12/2025 David A. Ricks President, Chair, and CEO 1,632 $644.77 $1,052,263
08/12/2025 Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm 1,000 $634.40 $634,405
08/12/2025 Gabrielle Sulzberger Director 117 $641.18 $75,018
08/12/2025 J. Erik Fyrwald Director 1,565 $642.33 $1,005,242
08/13/2025 Ralph Alvarez Director 758 $660.25 $500,473
08/15/2025 Lucas Montarce EVP & CFO 715 $691.79 $494,627
08/13/2025 Jacob Van Naarden EVP & Pres., Lilly Oncology 1,000 $647.36 $647,360

And Fortrea Holdings Inc (Symbol: FTRE), the #196 largest holding among components of the Vanguard Health Care ETF (VHT), shows 2 directors and officers as recently filing Form 4's indicating purchases. The ETF holds $2,853,738 worth of FTRE, which represents approximately 0.02% of the ETF's total assets at last check. The recent insider buying activity observed at FTRE is detailed in the table below:

FTRE — last trade: $10.65 — Recent Insider Buys:

Purchased Insider Title Shares Price/Share Value
08/11/2025 Peter M. Neupert Director 62,500 $6.51 $407,150
09/02/2025 Erin L. Russell Director 9,854 $10.15 $100,018

10 ETFs With Stocks That Insiders Are Buying »

Also see:

• Financial Stocks Hedge Funds Are Buying
• YETI Stock Predictions
• IG Historical Stock Prices

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.